Brief Report: "What Is This PrEP?"-Sources and Accuracy of HIV Pre-Exposure Prophylaxis (PrEP) Awareness Among Adolescent Girls and Young Women Attending Family Planning and Maternal Child Health Clinics in Western Kenya.
Journal
Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005
Informations de publication
Date de publication:
01 12 2021
01 12 2021
Historique:
received:
23
04
2021
accepted:
22
07
2021
pubmed:
12
8
2021
medline:
18
1
2022
entrez:
11
8
2021
Statut:
ppublish
Résumé
Pre-exposure prophylaxis (PrEP) delivery to adolescent girls and young women (AGYW) is scaling up in sub-Saharan African countries. Understanding how AGYW learn about PrEP is needed to inform programs seeking to reach AGYW with HIV prevention tools. AGYW (ages 15-24), attending routine family planning and maternal child health clinics in Kisumu, Kenya, participated in in-depth interviews. AGYW were recruited if they either declined or accepted PrEP when offered that day in clinic or were currently or previously on PrEP. Thematic analysis was used to identify key themes related to the type and quality of knowledge sources from which AGYW first became aware of PrEP. Overall, 140 in-depth interviews were conducted with AGYW. The median age was 21.5 years (interquartile range: 20.0-23.0), 65% of participants were married, and almost half (45.7%) were currently taking PrEP. Participants reported learning about PrEP from 3 primary sources: (1) clinic-based education; (2) friends, family, or other PrEP users; and (3) media and community outreach. Participants who reported learning about PrEP from friends or family were highly enthusiastic about PrEP. The accuracy and completeness of knowledge varied with most inaccuracies around the cost, dosing, and who benefits from PrEP. Community outreach campaigns provided fewer details, resulting in more inaccurate information and distrust of information received. PrEP information reaches AGYW through many sources with variable accuracy and completeness. Training providers and peer leaders to disseminate thorough and accurate PrEP information when counseling AGYW could positively impact acceptance and proper use.
Sections du résumé
BACKGROUND
Pre-exposure prophylaxis (PrEP) delivery to adolescent girls and young women (AGYW) is scaling up in sub-Saharan African countries. Understanding how AGYW learn about PrEP is needed to inform programs seeking to reach AGYW with HIV prevention tools.
METHODS
AGYW (ages 15-24), attending routine family planning and maternal child health clinics in Kisumu, Kenya, participated in in-depth interviews. AGYW were recruited if they either declined or accepted PrEP when offered that day in clinic or were currently or previously on PrEP. Thematic analysis was used to identify key themes related to the type and quality of knowledge sources from which AGYW first became aware of PrEP.
RESULTS
Overall, 140 in-depth interviews were conducted with AGYW. The median age was 21.5 years (interquartile range: 20.0-23.0), 65% of participants were married, and almost half (45.7%) were currently taking PrEP. Participants reported learning about PrEP from 3 primary sources: (1) clinic-based education; (2) friends, family, or other PrEP users; and (3) media and community outreach. Participants who reported learning about PrEP from friends or family were highly enthusiastic about PrEP. The accuracy and completeness of knowledge varied with most inaccuracies around the cost, dosing, and who benefits from PrEP. Community outreach campaigns provided fewer details, resulting in more inaccurate information and distrust of information received.
CONCLUSION
PrEP information reaches AGYW through many sources with variable accuracy and completeness. Training providers and peer leaders to disseminate thorough and accurate PrEP information when counseling AGYW could positively impact acceptance and proper use.
Identifiants
pubmed: 34379606
doi: 10.1097/QAI.0000000000002782
pii: 00126334-202112010-00005
pmc: PMC8556238
mid: NIHMS1731498
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
356-360Subventions
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI125498
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD094630
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD100201
Pays : United States
Organisme : PEPFAR
Pays : United States
Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
PEPFAR. Dreaming Of an AIDS-free Future G. PEPFAR:Washington, DC; 2018. Available at: https://www.pepfar.gov/documents/organization/287807.pdf .
UNAIDS. The Youth Buldge and HIV. Geneva, Switzerland: UNAIDS; 2018. Available at: http://www.unaids.org/sites/default/files/media_asset/the-youth-bulge-and-hiv_en.pdf .
Society for Adolescent Health and Medicine. HIV pre-exposure prophylaxis medication for adolescents and young adults: a position paper of the society for adolescent health and medicine. J Adolesc Heal 2018;63:513–516.
World Health Organization. WHO Implementation Tool for Pre-exposure Prophylaxis (PrEP) of HIV Infection. Module 8: Site Planning. Geneva, Switzerland: World Health Organization; 2017:14. Available at: https://www.who.int/hiv/pub/prep/prep-implementation-tool/en/ .
Hodges-Mameletzis I, Dalal S, Msimanga-Radebe B, et al. Going Global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health 2018;15:489–500.
National AIDS and STI Control Programme. Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Nairobi, Kenya: Kenya Ministry of Health; 2016 Editi.; 2016.
National AIDS and STI Control Programme, Ministry of Health. Framework for the Implementation of Pre-exposure Prophylaxis of HIV in Kenya. Vol 96. Nairobi, Kenya: Kenya Ministry of Health; 2017. Available at: www.nascop.or.ke .
Begnel ER, Escudero J, Mugambi M, et al. High pre-exposure prophylaxis awareness and willingness to pay for pre-exposure prophylaxis among young adults in Western Kenya: results from a population-based survey. Int J STD AIDS. 2020;31:454–459.
Pintye J, Kinuthia J, Allen Roberts D, et al. Integration of PrEP services into routine antenatal and postnatal care: experiences from an implementation program in western Kenya. J Acquir Immune Defic Syndr. 2018;79:590–595.
Mugwanya KK, Pintye J, Kinuthia J, et al. Integrating preexposure prophylaxis delivery in routine family planning clinics: a feasibility programmatic evaluation in Kenya. PLoS Med. 2019;16:22–29.
Kinuthia J, Pintye J, Abuna F, et al. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme. Lancet HIV. 2020;7:e38–e48.
Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–1288.
Attride-Sterling J. Thematic Networks: an analytics tool for qualitative research. Qual Res. 2001;1:385–405.
Prochaska JO, Velicer WF. The transtheoretical Model of health behavior change. Am J Heal Promot. 1997;12:38–48.
Dedoose Version 8.0.35, web application for managing, analyzing, and presenting qualitative and mixed method research data (2018). Los Angeles, CA: SocioCultural Research Consultants, LLC. Available at: www.dedoose.com .
Ajayi AI, Mudefi E, Yusuf MS, et al. Low awareness and use of pre-exposure prophylaxis among adolescents and young adults in high HIV and sexual violence prevalence settings. Medicine. 2019;98:43(e17716).
Haberer JE, Mugo N, Baeten JM, et al. PrEP as a lifestyle and investment for adolescent girls and young women in sub-saharan Africa. J Int Assoc Provid AIDS Care. 2019;18:1–5.